Smart Pill Technologies Market
Description
Smart Pill Technologies Market
Smart Pill Technologies is the use of advanced methods for the preparation of prescription pills which has revolutionized patient monitoring, diagnosis of diseases and improved drug delivery. Smart pill technologies is the converging link between digital technology and healthcare industries. These smart pills have many benefits other than providing signals and alerts when consumed. By programming the pill accordingly, it can trigger a reminder according to the remainder time whenever the pill needs to be consumed. It can alert the physician, patient, medical staff or the caretaker when the medicine has been consumed which will help in accurate documentation of patient compliance or adherence. It can also provide alerts if the pill hasn't been consumed on a timely routine since multiple medications need to be taken by a large number of patients. Physicians do a good job of triangulating medications with their patients, since new additions/OTC medications are not routinely documented. So with the use of smart pill technology, the data collected can further be of assistance by identifying potential drug-drug interactions, errors in dosage, schedule errors and help identify/prevent adverse events. Pills can also turn to be useful in sending alert signals when medicines are past their expiry date.Patients on medications such as antibiotics can be monitored and alerted to complete their course to ensure that drug resistance is not encountered.
Smart Pill Technologies Market: Drivers and Restraints
The Smart pill technologies market is a flourishing market and has tremendous opportunities in future. The market has a wide scope in the monitoring and diagnosis of diseases. The rising prevalence of Gastro-intestinal diseases is acting as the major driver in the market. According to Centers for Disease Control and Prevention (CDC) 2015, it is currently estimated that about 1 –1.3 Mn people suffer from IBD in the United States. Prevalence of Crohn's disease is 201 per 100,000 adults and Ulcerative colitis is 238 per 100,000 adults. Also the changing lifestyle related syndromes and disorders will further boost this market. Likewise the increasing disposable income to avail the evolving innovative technologies in the market will further help in penetration of the developed as well as developing countries. The rising geriatric population will also act as a driver since this segment of population is more prone to IBD, Ulcerative colitis and Crohn's disease. The World Health Organization (WHO) has estimated that by 2050 world’s geriatric population count will reach around 2 Bn which will definitely contribute to the rapid growth of this market. The chronic therapy monitoring can help in curtailing health care costs as well. To illustrate: the smart pill technology combination of an ambulatory monitoring with anti-thrombolytic drug can reduce the number of physicians visits and ensure that anti-thrombolytic therapy is adjusted remotely while ensuring compliance. Even so, all technological advancements of this segment come with some caveats. Barriers to technology such as age, cost and utility, pose challenges which the manufacturers should attempt to overcome. While customizability is the feature of smart pill market, it can also prove to be a hindrance and can be very cumbersome since it would be difficult to manufacture according to individual consumer needs. Furthermore, adaptability is also a point of concern and these parameters can thus act as a restraint in the market.
Smart Pill Technologies Market: Segmentation
The Smart pill technologies market is classified on the basis of application, disease indication and geography.
Based on application, the global smart pill technologies market is segmented into the following:
Capsule Endoscopy
Small Bowel Video Capsule Endoscopy
Colon Capsule Endoscopy
OMOM Capsule Endoscopy Platform
Small Bowel Capsule Endoscopy
Controllable Capsule Endoscopy
Storable Capsule Endoscope
Colon Capsule Endoscope
pH Capsule Wireless Monitoring System
Impedance–pH Monitoring System
MiroCam
Upgraded MiroCam and Advanced Capsule Endoscope
The ANKON MCE System
CapsoCam
Drug Delivery
Patient monitoring of cancer
Based on disease indication, the global smart pill technologies market is segmented into the following:
Occult GI Bleeding
Crohn’s Disease
Small Bowel Tumors
Celiac Disease
Inherited Polyposis Syndromes
Smart Pill Technologies Market: Overview
The smart pill technologies has recently entered the market and is rapidly penetrating the developed as well as developing countries. The growing demand and escalating adoption rate for monitoring and treating diseases by newly advanced technologies has given an impetus to the global smart pill technologies market. In the last few years the market has seen high percentage of acceptance towards usage due to non-invasiveness, better patient accessibility and thorough monitoring. Capsule endoscopy accounted for the highest revenue in 2014. The first capsule endoscope model, which is now regarded as a first-line tool for the detection of abnormalities of the small bowel, was the PillCam SB. It was approved in Japan in April 2007. GI monitoring application segment is expected to register fastest growth in the forecast period, amongst all other segments. In the coming years, global smart pill technologies market will witness significant developments in innovation of a wide range of new products that will require novel marketing approaches. The smart pill technologies market is currently underpenetrated and in its nascent stage of development. Although the maximum revenues are generated by the developed countries, it is also observed that CAGR in the developing countries are high. The reason for the growth in the CAGR can be attributed to the increasing awareness in the latest innovative testing methods and the continuously improving economic conditions.
Smart Pill Technologies Market: Region-wise Outlook
On the basis of geography, Global Smart pill technologies market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe collectively accounted for the largest market share in the overall smart pills technology market, in 2014. North America accounted for about half the share of market revenue in 2014. The growth in this region is primarily attributed to the early adoption of novel technologies, a large patient population, high disposable incomes and the fresh marketing and commercializing of smart pill products. Asia Pacific is expected to grow at a remarkable CAGR for smart pills technologies market due to increasing healthcare awareness.
Smart Pill Technologies Market: Key Players
Key players in the global Nucleic Acid Testing market include CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, and Bio-Images Research Limited, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc., Novartis AG, and Philips Healthcare.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America (U.S., Canada)
Latin America (Brazil, Mexico)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, BENELUX)
Eastern Europe (Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Table of Contents
250 Pages
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
- 5.3.1. Patient Monitoring Technology
- 5.3.2. Drug Delivery Technology
- 5.3.3. Capsule Endoscopy Technology
- 5.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
- 6.3.1. Drug Delivery
- 6.3.2. Vital Sign Monitoring
- 6.3.3. Targeted Drug Delivery
- 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Indication
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2017-2021
- 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032
- 7.3.1. Small Bowel Tumors
- 7.3.2. Occult GI Bleeding
- 7.3.3. Crohn’s Disease
- 7.3.4. Celiac Disease
- 7.3.5. Inherited Polyposis Syndromes
- 7.3.6. Others
- 7.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2021
- 7.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Target Area
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size Value (US$ Mn) Analysis By Target Area, 2017-2021
- 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Target Area, 2022-2032
- 8.3.1. Esophagus
- 8.3.2. Stomach
- 8.3.3. Small Intestine
- 8.3.4. Large Intestine
- 8.4. Y-o-Y Growth Trend Analysis By Target Area, 2017-2021
- 8.5. Absolute $ Opportunity Analysis By Target Area, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
- 9.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
- 9.3.1. Hospitals
- 9.3.2. Clinics
- 9.3.3. Academic & Research Institutes
- 9.3.4. Home Care Settings
- 9.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 9.5. Absolute $ Opportunity Analysis By End User, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 10.1. Introduction
- 10.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 10.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. East Asia
- 10.3.5. South Asia & Pacific
- 10.3.6. MEA
- 10.4. Market Attractiveness Analysis By Region
- 11. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. U.K.
- 11.2.1.2. Canada
- 11.2.2. By Technology
- 11.2.3. By Application
- 11.2.4. By Disease Indication
- 11.2.5. By Target Area
- 11.2.6. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Technology
- 11.3.3. By Application
- 11.3.4. By Disease Indication
- 11.3.5. By Target Area
- 11.3.6. By End User
- 11.4. Key Takeaways
- 12. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. Brazil
- 12.2.1.2. Mexico
- 12.2.1.3. Rest of Latin America
- 12.2.2. By Technology
- 12.2.3. By Application
- 12.2.4. By Disease Indication
- 12.2.5. By Target Area
- 12.2.6. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Technology
- 12.3.3. By Application
- 12.3.4. By Disease Indication
- 12.3.5. By Target Area
- 12.3.6. By End User
- 12.4. Key Takeaways
- 13. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. Germany
- 13.2.1.2. U.K.
- 13.2.1.3. France
- 13.2.1.4. Spain
- 13.2.1.5. Italy
- 13.2.1.6. Rest of Europe
- 13.2.2. By Technology
- 13.2.3. By Application
- 13.2.4. By Disease Indication
- 13.2.5. By Target Area
- 13.2.6. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Technology
- 13.3.3. By Application
- 13.3.4. By Disease Indication
- 13.3.5. By Target Area
- 13.3.6. By End User
- 13.4. Key Takeaways
- 14. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
- 14.2.1.1. China
- 14.2.1.2. Japan
- 14.2.1.3. South Korea
- 14.2.2. By Technology
- 14.2.3. By Application
- 14.2.4. By Disease Indication
- 14.2.5. By Target Area
- 14.2.6. By End User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Technology
- 14.3.3. By Application
- 14.3.4. By Disease Indication
- 14.3.5. By Target Area
- 14.3.6. By End User
- 14.4. Key Takeaways
- 15. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 15.2.1. By Country
- 15.2.1.1. India
- 15.2.1.2. Thailand
- 15.2.1.3. Indonesia
- 15.2.1.4. Malaysia
- 15.2.1.5. Singapore
- 15.2.1.6. Australia
- 15.2.1.7. New Zealand
- 15.2.1.8. Rest of South Asia & Pacific
- 15.2.2. By Technology
- 15.2.3. By Application
- 15.2.4. By Disease Indication
- 15.2.5. By Target Area
- 15.2.6. By End User
- 15.3. Market Attractiveness Analysis
- 15.3.1. By Country
- 15.3.2. By Technology
- 15.3.3. By Application
- 15.3.4. By Disease Indication
- 15.3.5. By Target Area
- 15.3.6. By End User
- 15.4. Key Takeaways
- 16. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 16.2.1. By Country
- 16.2.1.1. GCC Countries
- 16.2.1.2. South Africa
- 16.2.1.3. Israel
- 16.2.1.4. Rest of MEA
- 16.2.2. By Technology
- 16.2.3. By Application
- 16.2.4. By Disease Indication
- 16.2.5. By Target Area
- 16.2.6. By End User
- 16.3. Market Attractiveness Analysis
- 16.3.1. By Country
- 16.3.2. By Technology
- 16.3.3. By Application
- 16.3.4. By Disease Indication
- 16.3.5. By Target Area
- 16.3.6. By End User
- 16.4. Key Takeaways
- 17. Key Countries Market Analysis
- 17.1. U.K.
- 17.1.1. Pricing Analysis
- 17.1.2. Market Share Analysis, 2021
- 17.1.2.1. By Technology
- 17.1.2.2. By Application
- 17.1.2.3. By Disease Indication
- 17.1.2.4. By Target Area
- 17.1.2.5. By End User
- 17.2. Canada
- 17.2.1. Pricing Analysis
- 17.2.2. Market Share Analysis, 2021
- 17.2.2.1. By Technology
- 17.2.2.2. By Application
- 17.2.2.3. By Disease Indication
- 17.2.2.4. By Target Area
- 17.2.2.5. By End User
- 17.3. Brazil
- 17.3.1. Pricing Analysis
- 17.3.2. Market Share Analysis, 2021
- 17.3.2.1. By Technology
- 17.3.2.2. By Application
- 17.3.2.3. By Disease Indication
- 17.3.2.4. By Target Area
- 17.3.2.5. By End User
- 17.4. Mexico
- 17.4.1. Pricing Analysis
- 17.4.2. Market Share Analysis, 2021
- 17.4.2.1. By Technology
- 17.4.2.2. By Application
- 17.4.2.3. By Disease Indication
- 17.4.2.4. By Target Area
- 17.4.2.5. By End User
- 17.5. Germany
- 17.5.1. Pricing Analysis
- 17.5.2. Market Share Analysis, 2021
- 17.5.2.1. By Technology
- 17.5.2.2. By Application
- 17.5.2.3. By Disease Indication
- 17.5.2.4. By Target Area
- 17.5.2.5. By End User
- 17.6. U.K.
- 17.6.1. Pricing Analysis
- 17.6.2. Market Share Analysis, 2021
- 17.6.2.1. By Technology
- 17.6.2.2. By Application
- 17.6.2.3. By Disease Indication
- 17.6.2.4. By Target Area
- 17.6.2.5. By End User
- 17.7. France
- 17.7.1. Pricing Analysis
- 17.7.2. Market Share Analysis, 2021
- 17.7.2.1. By Technology
- 17.7.2.2. By Application
- 17.7.2.3. By Disease Indication
- 17.7.2.4. By Target Area
- 17.7.2.5. By End User
- 17.8. Spain
- 17.8.1. Pricing Analysis
- 17.8.2. Market Share Analysis, 2021
- 17.8.2.1. By Technology
- 17.8.2.2. By Application
- 17.8.2.3. By Disease Indication
- 17.8.2.4. By Target Area
- 17.8.2.5. By End User
- 17.9. Italy
- 17.9.1. Pricing Analysis
- 17.9.2. Market Share Analysis, 2021
- 17.9.2.1. By Technology
- 17.9.2.2. By Application
- 17.9.2.3. By Disease Indication
- 17.9.2.4. By Target Area
- 17.9.2.5. By End User
- 17.10. China
- 17.10.1. Pricing Analysis
- 17.10.2. Market Share Analysis, 2021
- 17.10.2.1. By Technology
- 17.10.2.2. By Application
- 17.10.2.3. By Disease Indication
- 17.10.2.4. By Target Area
- 17.10.2.5. By End User
- 17.11. Japan
- 17.11.1. Pricing Analysis
- 17.11.2. Market Share Analysis, 2021
- 17.11.2.1. By Technology
- 17.11.2.2. By Application
- 17.11.2.3. By Disease Indication
- 17.11.2.4. By Target Area
- 17.11.2.5. By End User
- 17.12. South Korea
- 17.12.1. Pricing Analysis
- 17.12.2. Market Share Analysis, 2021
- 17.12.2.1. By Technology
- 17.12.2.2. By Application
- 17.12.2.3. By Disease Indication
- 17.12.2.4. By Target Area
- 17.12.2.5. By End User
- 17.13. India
- 17.13.1. Pricing Analysis
- 17.13.2. Market Share Analysis, 2021
- 17.13.2.1. By Technology
- 17.13.2.2. By Application
- 17.13.2.3. By Disease Indication
- 17.13.2.4. By Target Area
- 17.13.2.5. By End User
- 17.14. Thailand
- 17.14.1. Pricing Analysis
- 17.14.2. Market Share Analysis, 2021
- 17.14.2.1. By Technology
- 17.14.2.2. By Application
- 17.14.2.3. By Disease Indication
- 17.14.2.4. By Target Area
- 17.14.2.5. By End User
- 17.15. Indonesia
- 17.15.1. Pricing Analysis
- 17.15.2. Market Share Analysis, 2021
- 17.15.2.1. By Technology
- 17.15.2.2. By Application
- 17.15.2.3. By Disease Indication
- 17.15.2.4. By Target Area
- 17.15.2.5. By End User
- 17.16. Malaysia
- 17.16.1. Pricing Analysis
- 17.16.2. Market Share Analysis, 2021
- 17.16.2.1. By Technology
- 17.16.2.2. By Application
- 17.16.2.3. By Disease Indication
- 17.16.2.4. By Target Area
- 17.16.2.5. By End User
- 17.17. Singapore
- 17.17.1. Pricing Analysis
- 17.17.2. Market Share Analysis, 2021
- 17.17.2.1. By Technology
- 17.17.2.2. By Application
- 17.17.2.3. By Disease Indication
- 17.17.2.4. By Target Area
- 17.17.2.5. By End User
- 17.18. Australia
- 17.18.1. Pricing Analysis
- 17.18.2. Market Share Analysis, 2021
- 17.18.2.1. By Technology
- 17.18.2.2. By Application
- 17.18.2.3. By Disease Indication
- 17.18.2.4. By Target Area
- 17.18.2.5. By End User
- 17.19. New Zealand
- 17.19.1. Pricing Analysis
- 17.19.2. Market Share Analysis, 2021
- 17.19.2.1. By Technology
- 17.19.2.2. By Application
- 17.19.2.3. By Disease Indication
- 17.19.2.4. By Target Area
- 17.19.2.5. By End User
- 17.20. GCC Countries
- 17.20.1. Pricing Analysis
- 17.20.2. Market Share Analysis, 2021
- 17.20.2.1. By Technology
- 17.20.2.2. By Application
- 17.20.2.3. By Disease Indication
- 17.20.2.4. By Target Area
- 17.20.2.5. By End User
- 17.21. South Africa
- 17.21.1. Pricing Analysis
- 17.21.2. Market Share Analysis, 2021
- 17.21.2.1. By Technology
- 17.21.2.2. By Application
- 17.21.2.3. By Disease Indication
- 17.21.2.4. By Target Area
- 17.21.2.5. By End User
- 17.22. Israel
- 17.22.1. Pricing Analysis
- 17.22.2. Market Share Analysis, 2021
- 17.22.2.1. By Technology
- 17.22.2.2. By Application
- 17.22.2.3. By Disease Indication
- 17.22.2.4. By Target Area
- 17.22.2.5. By End User
- 18. Market Structure Analysis
- 18.1. Competition Dashboard
- 18.2. Competition Benchmarking
- 18.3. Market Share Analysis of Top Players
- 18.3.1. By Regional
- 18.3.2. By Technology
- 18.3.3. By Application
- 18.3.4. By Disease Indication
- 18.3.5. By Target Area
- 18.3.6. By End User
- 19. Competition Analysis
- 19.1. Competition Deep Dive
- 19.1.1. Boston Scientific Corporation
- 19.1.1.1. Overview
- 19.1.1.2. Product Portfolio
- 19.1.1.3. Profitability by Market Segments
- 19.1.1.4. Sales Footprint
- 19.1.1.5. Strategy Overview
- 19.1.1.5.1. Marketing Strategy
- 19.1.2. GE Healthcare
- 19.1.2.1. Overview
- 19.1.2.2. Product Portfolio
- 19.1.2.3. Profitability by Market Segments
- 19.1.2.4. Sales Footprint
- 19.1.2.5. Strategy Overview
- 19.1.2.5.1. Marketing Strategy
- 19.1.3. Microchips
- 19.1.3.1. Overview
- 19.1.3.2. Product Portfolio
- 19.1.3.3. Profitability by Market Segments
- 19.1.3.4. Sales Footprint
- 19.1.3.5. Strategy Overview
- 19.1.3.5.1. Marketing Strategy
- 19.1.4. Novartis AG
- 19.1.4.1. Overview
- 19.1.4.2. Product Portfolio
- 19.1.4.3. Profitability by Market Segments
- 19.1.4.4. Sales Footprint
- 19.1.4.5. Strategy Overview
- 19.1.4.5.1. Marketing Strategy
- 19.1.5. Olympus Medical Technology
- 19.1.5.1. Overview
- 19.1.5.2. Product Portfolio
- 19.1.5.3. Profitability by Market Segments
- 19.1.5.4. Sales Footprint
- 19.1.5.5. Strategy Overview
- 19.1.5.5.1. Marketing Strategy
- 19.1.6. Phillips
- 19.1.6.1. Overview
- 19.1.6.2. Product Portfolio
- 19.1.6.3. Profitability by Market Segments
- 19.1.6.4. Sales Footprint
- 19.1.6.5. Strategy Overview
- 19.1.6.5.1. Marketing Strategy
- 19.1.7. Otsuka America Pharmaceutical, Inc
- 19.1.7.1. Overview
- 19.1.7.2. Product Portfolio
- 19.1.7.3. Profitability by Market Segments
- 19.1.7.4. Sales Footprint
- 19.1.7.5. Strategy Overview
- 19.1.7.5.1. Marketing Strategy
- 19.1.8. Yooma Wellness Inc.
- 19.1.8.1. Overview
- 19.1.8.2. Product Portfolio
- 19.1.8.3. Profitability by Market Segments
- 19.1.8.4. Sales Footprint
- 19.1.8.5. Strategy Overview
- 19.1.8.5.1. Marketing Strategy
- 19.1.9. Medtronic Private Limited
- 19.1.9.1. Overview
- 19.1.9.2. Product Portfolio
- 19.1.9.3. Profitability by Market Segments
- 19.1.9.4. Sales Footprint
- 19.1.9.5. Strategy Overview
- 19.1.9.5.1. Marketing Strategy
- 19.1.10. CapsoVision, Inc.
- 19.1.10.1. Overview
- 19.1.10.2. Product Portfolio
- 19.1.10.3. Profitability by Market Segments
- 19.1.10.4. Sales Footprint
- 19.1.10.5. Strategy Overview
- 19.1.10.5.1. Marketing Strategy
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
